We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
+26.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.68T
AUM Growth
+$637B
(+16%)
Cap. Flow
+$33.9B
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
32.56%
Holding
4,163
New
102
Increased
2,573
Reduced
1,196
Closed
71
Avg Time Held
1
quarter
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$4.57B |
| 2 |
SPCX
SpaceX
SPCX
|
+$4.51B |
| 3 |
Marvell Technology
MRVL
|
+$3.77B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.69B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.59B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.69B |
| 3 |
Salesforce
CRM
|
+$1.28B |
| 4 |
JPMorgan Chase
JPM
|
+$1.15B |
| 5 |
HOLX
Hologic
HOLX
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Financials | 12.19% |
| 3 | Industrials | 9.6% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4051
HCW Biologics
HCWB
$3.78M
| $9.99K | ﹤0.01% |
2,003
-1
| -0% | -$6 |
2026 Q1
1 quarter
|
|
4052
Alzamend Neuro
ALZN
$5.94M
| $9.07K | ﹤0.01% |
7,556
+3,156
| +72% | +$3.5K |
2026 Q1
1 quarter
|
|
4053
Greenwave Technology Solutions
GWAV
$2.03M
| $9.04K | ﹤0.01% |
3,045
| – | – |
2026 Q1
1 quarter
|
|
4054
Generation Income Properties
GIPR
$1.23M
| $8.47K | ﹤0.01% |
5,074
| – | – |
2026 Q1
1 quarter
|
|
|
INIO
4055
INNIO N.V.
INIO
$14.8B
| $7.99K | ﹤0.01% |
+202
| New | +$7.19K |
2026 Q2
0 quarters
|
|
|
SNYR
4056
DELISTED
Synergy CHC Corp
SNYR
| $7.74K | ﹤0.01% |
38,909
-50,861
| -57% | -$18K |
2026 Q1
1 quarter
|
|
|
SOBR
4057
DELISTED
SOBR SAFE INC
SOBR
| $7.63K | ﹤0.01% |
10,363
| – | – |
2026 Q1
1 quarter
|
|
|
CYCU
4058
Cycurion Inc
CYCU
$105M
| $7.48K | ﹤0.01% |
1,616
| – | – |
2026 Q1
1 quarter
|
|
|
NCL
4059
DELISTED
Northann Corp
NCL
| $7.24K | ﹤0.01% |
45,539
| – | – |
2026 Q1
1 quarter
|
|
|
PWCM
4060
PowerCompute Inc
PWCM
$1.68M
| $7.19K | ﹤0.01% |
1,931
| – | – |
2026 Q1
1 quarter
|
|
4061
Nocera
NCRA
$3.92M
| $6.81K | ﹤0.01% |
2,389
| – | – |
2026 Q1
1 quarter
|
|
4062
Arcadia Biosciences
RKDA
$679K
| $6.55K | ﹤0.01% |
9,644
| – | – |
2026 Q1
1 quarter
|
|
4063
Jet.AI
JTAI
$2.26M
| $5.7K | ﹤0.01% |
+700
| New | +$5.28K |
2026 Q2
0 quarters
|
|
|
LIMN
4064
Liminatus Pharma
LIMN
$5.31M
| $5.55K | ﹤0.01% |
1,009
| – | – |
2026 Q1
1 quarter
|
|
4065
Sadot Group
SDOT
$18.8M
| $5.37K | ﹤0.01% |
153
| – | – |
2026 Q1
1 quarter
|
|
|
CJMB
4066
Callan JMB Inc
CJMB
$15.4M
| $5.36K | ﹤0.01% |
6,664
| – | – |
2026 Q1
1 quarter
|
|
4067
Professional Diversity Network
IPDN
$2.13M
| $5.22K | ﹤0.01% |
253
+20
| +9% | +$456 |
2026 Q1
1 quarter
|
|
|
DAIC
4068
CID HoldCo Inc
DAIC
$6.45M
| $5K | ﹤0.01% |
2,871
-1
| -0% | -$4 |
2026 Q1
1 quarter
|
|
4069
BioRestorative Therapies
BRTX
$3.2M
| $4.88K | ﹤0.01% |
+649
| New | +$3.8K |
2026 Q2
0 quarters
|
|
4070
Calidi Biotherapeutics
CLDI
$2.79M
| $4.34K | ﹤0.01% |
1,594
| – | – |
2026 Q1
1 quarter
|
|
4071
GeoVax Labs
GOVX
$2.99M
| $4.09K | ﹤0.01% |
3,217
| – | – |
2026 Q1
1 quarter
|
|
4072
Ensysce Biosciences
ENSC
$7.84M
| $3.73K | ﹤0.01% |
12,854
| – | – |
2026 Q1
1 quarter
|
|
4073
Cellebrite
CLBT
$2.79B
| $3.67K | ﹤0.01% |
+251
| New | +$3.32K |
2026 Q2
0 quarters
|
|
4074
Greenlane Holdings
GNLN
$2M
| $3.1K | ﹤0.01% |
1,282
-1
| -0.1% | -$4 |
2026 Q1
1 quarter
|
|
4075
Focus Universal
FCUV
$3.14M
| $2.65K | ﹤0.01% |
697
-1
| -0.1% | -$6 |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.2%. Vanguard Capital Management opened 102 new positions and exited 71, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
- Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
- Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
- Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
- Vanguard Capital Management opened 102 new positions and closed 71 in Q2 2026.
- Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.